“Vortioxetine Improves Gastrointestinal Motility and Reduces Intestinal Inflammation in a Cuprizone-Induced Multiple Sclerosis Model in Mice”. Annals of Medical Research, vol. 33, no. 5, May 2026, pp. 192-8, http://www.annalsmedres.org/index.php/aomr/article/view/4909.